Open elevated plus maze-induced antinociception in rats: A non-opioid type of pain inhibition?

Physiology and Behavior

Volumn 96, Issue 3, 2009, Pages 440-447

  Cornélio, Alianda Maira ^a   Nunes de Souza, Ricardo Luiz ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Adrenalectomy; Antinociception; Formalin test; Naltrexone; Open elevated plus maze; Tail flick test

Indexed keywords

FORMALDEHYDE; MORPHINE; NALTREXONE; WATER;

ADRENALECTOMY; ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; CROSS TOLERANCE; LICKING; MALE; MAZE TEST; NOCICEPTION; NONHUMAN; PAIN; PRIORITY JOURNAL; RAT; TAIL FLICK TEST;

ADAPTATION, PHYSIOLOGICAL; ADRENALECTOMY; ANALGESICS, OPIOID; ANALYSIS OF VARIANCE; ANIMALS; DRUG TOLERANCE; HABITUATION, PSYCHOPHYSIOLOGIC; INHIBITION (PSYCHOLOGY); MALE; MAZE LEARNING; MORPHINE; NALTREXONE; NARCOTIC ANTAGONISTS; PAIN; PAIN THRESHOLD; RATS; STRESS, PSYCHOLOGICAL;

EID: 58649122870     PISSN: 00319384     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.physbeh.2008.11.007     Document Type: Article

References (60)

1. Deakin J.F.W., and Graeff F.G. 5-HT and mechanisms of defense. J Psychopharmacol 5 (1991) 305-315
2. Kelly D.D. Stress induced analgesia. Ann. N. Y. Acad. Sci. New York (1986) 467
3. Rodgers R.J. Neuropharmacological aspects of adaptative pain inhibition in murine "victims" of aggression. Agress Behav 21 (1995) 29-39
4. Watkins L.R., and Mayer D.J. Organization of endogenous opiate and nonopiate pain control systems. Science 216 (1982) 1185-1192
5. Fardin V., Oliveiras J.L., and Besson J.M. A reinvestigation of the analgesic effects induced by stimulation of the periaqueductal gray matter in the rat I. The production of behavioral side effects together with analgesia. Brain Res 306 (1984) 105-123
6. Terman G.W., Shavit Y., Lewis J.W., Cannon J.T., and Liebeskind J.C. Intrinsic mechanisms of pain inhibition. Activation by stress. Science 226 (1984) 1270-1277
7. Fanselow M.S. The midbrain periaqueductal gray as a coordinator of action in response to fear and anxiety. In: Depaulis A., and Bandler (Eds). The Midbrain Periaqueductal Gray Matter (1991), Plenum Press, New York 151-173
8. Lichtman A.H., and Fanselow M.S. Cats produce analgesia in rats on the tail-flick test: naltrexone sensitivity is determined by the nociceptive test stimulus. Brain Res 533 (1990) 91-94
9. Lester L.S., and Fanselow M.S. Exposure to a cat produces opioid analgesia in rats. Behav Neurosci 99 4 (1985) 756-759
10. Miczek K.A., Thompson M.L., and Shuster L. Opioid-like analgesia in defeat mice. Science 215 (1982) 1520-1522
11. Rodgers R.J., and Hendrie C.A. Social conflit activates status-dependent endogenous analgesic or hyperalgesic mechanisms in male mice: effects of naloxone on nociception and behaviour. Physiol Behav 30 (1983) 775-780
12. Rodgers R.J., and Randall J.I. Acute non-opioid analgesia in defeated male mice. Physiol Behav 36 (1986) 947-950
13. 1A anxiolytics, buspirone, gepirone and ipsapirone. Psychopharmacology (Berl) 99 (1989) 374-380
14. 3 receptor antagonist, GR 38032F, on non-opioid defeat analgesia in male mice. Neuropharmacology 29 1 (1990) 17-23
15. Canto-de-Souza A., Nunes-de-Souza R.L., Pelá I.R., and Graeff F.G. High intensity social conflict in the Swiss albino mouse induces analgesia modulated by 5-HT1A recpetors. Pharmacol Biochem Behav 56 (1997) 481-486
16. Rodgers R.J., and Randall J.I. Environmentally induced analgesia: situational factors, mechanisms and significance. In: Rodgers R.J., and Cooper S.J. (Eds). Endorphins, opiates and behavioural processes (1988), John Wiley, Chichester 107-142
17. Rodgers R.J., and Randall J.I. Benzodiazepine ligands, nociception and 'defeat' analgesia in male mice. Psychopharmacology (Berl) 91 (1987) 305-315
18. Bolles R.C., and Fanselow M.S.A. Perceptual-defensive-recuperative model of fear and pain. Behav Brain Sci 3 (1980) 291-322
19. Lee C., and Rodgers R.J. Antinociceptive effects of elevated plus-maze exposure: influence of opiate receptor manipulations. Psychopharmacology (Berl) 102 (1990) 507-513
20. Taukulis H.K., and Goggin C.E. Diazepam-stress interactions in the rat: effects on autoanalgesia and a plus-maze model of anxiety. Behav. Neural Biol. 53 (1990) 205-216
21. Conceição I.M., Maiolini J.R.M., Mattia N., Vital M.A., Santos B.R., Smaili S., and Frussa-Filho R. Anxiety-induced antinociception in the mouse. Braz J Med Biol Res 25 (1992) 831-834
22. Pellow S., Chopin P., File S.E., and Briley M. Validation of open: closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 14 (1985) 149-167
23. Handley S.L., and Mithani S. Effects of alpha-adrenoceptor agonist in a maze-exploration model of "fear-motivated behaviour". Naunyn Schmiedebergs Arch Pharmacol. 327 (1984) 1-5
24. Stephens D.N., Meldrum B.S., Weidmann R., Schneider C., and Grutsner M. Does the excitatory amino acid receptor antagonist 2-APH exhibit anxiolytic activity?. Psychopharmacology (Berl) 90 (1986) 166-169
25. Lister R.G. The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology (Berl) 92 (1987) 180-185
26. Lee C., and Rodgers R.J. Effects of buspirone on antinociceptive and behavioural responses to the elevated plus-maze in mice. Behav Pharmacol 2 (1991) 491-496
27. Rodgers R.J., Lee C., and Shepherd J.K. Effects of diazepam on behavioural and antinociceptive responses to the elevated plus-maze in male mice depend upon treatment regimen and prior maze experience. Psychopharmacology (Berl) 106 (1992) 102-110
28. Nunes-de-Souza R.L., Canto-de-Souza A., Da-Costa M., Fornari R.V., Graeff F.G., and Pelá I.R. Anxiety-induced antinociception in mice: effects of systemic and intra-amygdala administration of 8-OH-DPAT and midazolam. Psychopharmacology (Berl) 150 (2000) 300-310
29. Mendes-Gomes J., and Nunes-de-Souza R.L. Concurrent nociceptive stimulation impairs the anxiolytic effect of midazolam injected into the periaqueductal gray in mice. Brain Res 1047 (2005) 97-104
30. Van de Kar L.D., and Blair M.L. Forebrain pathways mediating stress-induced hormone secretion. Front Neuroendocrinol. 20 (1999) 1-48
31. Carrasco G.A., and Van de Kar L.D. Neuroendocrine pharmacology of stress. Eur J Pharmacol 463 (2003) 235-272
32. Bogdanov A.I., and Yarushkina N.N. The relationship between analgesia and corticosteroid levels in rats. Neurosc Behav Physiol 30 (2000) 487-489
33. Bogdanov A.I., and Yarushkina N.N. Mechanisms of the effects of adrenocorticotropic hormone on pain sensitivity in rats. Neurosc Behav Physiol 33 (2003) 795-798
34. Mikics E., Barsy B., Barsvári B., and Haller J. Behavioral specificity of non genomic glucocorticoid effects in rats: effects on risk assessment in the elevated plus-maze and the open-field. Horm and Behav 48 (2005) 152-162
35. Albrechet-Souza L., Cristina de Carvalho M., Rodrigues Franci C., and Brandão M.L. Increases in plasma corticosterone and stretched-attend postures in rats naïve and previously exposed to the elevated plus-maze are sensitive to the anxiolytic-like effects of midazolam. Horm and Behav 52 (2007) 267-273
36. Rodgers R.J., and Shepherd J.K. Effects of an endogenous anxiolytic adrenal steroid, alpha-THDOC, on non-opioid defeat analgesia in male mice: interaction with Ro15-1788. J Psychopharmacol 2 (1988) 150-158
37. Powell K.J., Abul-Husn N.S., Jhamandas A., Olmstead M.C., Beninger R.J., and Jhamandas K. Paradoxical effects of the opioid antagonist naltrexone on morphine analgesia, tolerance, and reward in rats. J Pharmacol Exp Ther 300 (2002) 588-596
38. Rebouças E.C.C., Segato E.N., Kishi R., Freitas R.L., Savoldi M., Morato S., and Coimbra N.C. Effect of the blockade of μ1-opioid and 5HT2A-serotonergic/α1-noradrenergic receptors on sweet-substance-induced analgesia. Psychopharmacology (Berl) 179 (2005) 349-355
39. Tsuchiya T., Takeuchi T., Hayashida K., Shimizu H., Ando K., and Harada E. Milk-derived lactoferrin may block tolerance to morphine analgesia. Brain Res 1068 (2006) 102-108
40. Siegfried B., Netto C.A., and Izquierdo I. Exposure to novelty induces naltrexone-reversible analgesia in rats. Behav Neurosci 101 (1987) 436-438
41. Abbott F.V., Franklin K.B.J., and Westbrook R.F. The formalin test: scoring properties of the first and second phases of the pain response in rats. Pain 60 (1995) 91-102
42. Le Bars D., Gozariu M., and Cadden S.W. Animal models of nociception. Pharmacol Rev 53 (2001) 597-652
43. Mao J., Price D.D., and Mayer D.J. Thermal hyperalgesia in association with the development of morphine tolerance in rats: roles of excitatory amino acid receptors and protein kinase C. J Neurosci 14 (1994) 2301-2312
44. Mao J., Sung B., and Ji R.R. Chronic morphine induces downregulation of spinal glutamate transporters: implications in morphine tolerance and abnormal pain sensitivity. J Neurosci 22 (2002) 8312-8323
45. Gardell L.R., King T., Ossipov M.H., Rice K.C., Lai J., Vanderah T.W., and Porreca F. Opioid receptor-mediated hyperalgesia and antinociceptive tolerance induced by sustained opiate delivery. Neurosci Lett 396 (2006) 44-49
46. Mao J., Price D.D., and Mayer D.J. Mechanisms of hyperalgesia and morphine tolerance a current view of their possible interactions. Pain 62 (1995) 259-274
47. Ossipov M.H., Lai J., King T., Vanderah T.W., and Porreca F. Underlying mechanisms of pronociceptive consequences of prolonged morphine exposure. Biopolymers 80 (2005) 319-324
48. Dong Z., Mao R., Han H., Cao J., and Xu L. Morphine withdrawal modifies antinociceptive effects of acute morphine in rats. Biochem Biophys Res Commun 346 (2006) 578-582
49. Helm S., Trescot A.M., Colson J., Sehgal N., and Silverman S. Opioid antagonists, partial agonists, and agonists/antagonists: the role of office-based detoxification. Pain Physician 11 (2008) 225-235
50. Choi S.S., Han K.J., Lee H.K., Han E.J., and Suh H.W. Possible antinociceptive mechanisms of opioid receptor antagonists in the mouse formalin test. Pharmacol Biochem Behav 75 (2003) 447-457
51. McNaulL B., Trang T., Sutak M., and Jhamandas K. Inhibition of tolerance to spinal morphine antinociception by low doses of opioid receptor antagonists. Eur J Pharmacol 560 (2007) 132-141
52. Taylor B.K., Akana S.F., Peterson M.A., Dallman M.F., and Basbaum A.I. Pituitary-adrenocortical responses to persistent noxious stimuli in the awake rat: endogenous corticosterone does not reduce nociception in the formalin test. Endocrinology 139 (1998) 2407-2413
53. Rodgers R.J., Haller J., Holmes A., Halas Z.J., Walton T.J., and Brain P.F. Corticosterone response to the plus-maze: high correlation with risk assessment in rats and mice. Physiol Behav 68 (1999) 47-53
54. Vissers K.C., De Jongh R.F., Crul B.J.P., Vinken P., and Meert T.F. Adrenalectomy affects pain behavior of rats after formalin injection. Life Sci 74 (2004) 1243-1251
55. Netto C.A., Siegfried B., and Izquierdo I. Analgesia induced by exposure to a novel environment in rats: effect of concurrent and post-training stressful stimulation. Behav Neural Biol 48 (1987) 304-309
56. Siegfried B., and Nunes-de-Souza R.L. NMDA receptors blockade in the periaqueductal gray prevents stress-induced analgesia in attacked mice. Eur J Pharmacol 168 (1989) 239-242
57. Siegfried B., Frischknecht H.R., and Nunes-de-Souza R.L. An ethological model for the study of activation and interaction of pain, memory and defensive systems in the attacked mouse. Role of endogenous opioids. Neurosci Biobehav Rev 14 (1990) 481-490
58. Harris J.A. Descending antinociceptive mechanisms in the brainstem: their role in the animal`s defensive system. J Physiol 90 (1996) 15-25
59. Canto-de-Souza A., Nunes-de-Souza R.L., Pelá I.R., and Graeff F.G. Involvement of the midbrain periaqueductal gray 5-HT1A receptors in social conflict induced analgesia in mice. Eur J Pharmacol 345 (1998) 253-256
60. Palazzos E., de Novellis V., Marabese I., Rossi F., and Maione S. Metabotropic glutamate and cannabinoid receptor crosstalk in periaqueductal grey pain processing. Curr Neuropharmacol 4 3 (2006) 225-231